Brief: Outlook Therapeutics Provides Update On Type A Meeting With FDA
29/09/2025 14:21
Sept 29 (Reuters) - Outlook Therapeutics Inc OTLK.O: OUTLOOK THERAPEUTICS PROVIDES UPDATE ON TYPE A MEETING WITH FDA OUTLOOK THERAPEUTICS INC - TO RESUBMIT BLA BY END OF 2025 Source text: ID:nGNXbTrqzV Further company coverage: OTLK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce